Report for the three months ended 31 March 2024
May 14, 2024 01:30 ET
|
Orrön Energy AB
Highlights Power generation in the first quarter amounted to 274 GWh, which is a record high quarterly production for the Company.Sale of the 50 percent interest in the non-core Leikanger...
Ensu - Ex. Repair Issue Today
May 14, 2024 01:30 ET
|
Ensurge Micropower ASA
Issuer name: Ensurge Micropower ASA Ex. date: 14 May 2024 Type of corporate action: Possible repair issue/subsequent offering This information is published in accordance with the requirements of...
Ensu - Ex. Reparasjonsemisjon i Dag
May 14, 2024 01:30 ET
|
Ensurge Micropower ASA
Utstedernavn: Ensurge Micropower ASA Ex. Dato: 14. mai 2024 Type selskapshandling: Potensiell reparasjonsemisjon Denne informasjonen offentliggjøres i henhold til kravene i Løpende...
Number of Shares in eQ Plc has Increased through Subscription with Stock Options
May 14, 2024 01:30 ET
|
eQ Oyj
eQ Plc Total Number of Voting Rights and Capital14 May 2024, at 8.30 a.m. A total number of 182,500 new shares in eQ Plc have been subscribed for with stock options of eQ Plc’s option scheme...
BGHL (EUR): NAV(s)
May 14, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
BGHL (GBP): NAV(s)
May 14, 2024 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer
May 14, 2024 01:15 ET
|
Nykode Therapeutics ASA
OSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,...
Oncolytic Virus Therapy Market Size Clinical Trials Sales Forecast 2030
May 14, 2024 01:08 ET
|
KuicK Research
Delhi, May 14, 2024 (GLOBE NEWSWIRE) -- Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030 Report Highlights: Global Oncolytic Virus Immunotherapy Therapy...
OKX Wallet Announces Integration of KyberSwap for Enhanced Decentralized Trading
May 14, 2024 01:06 ET
|
OKX
SINGAPORE, May 14, 2024 (GLOBE NEWSWIRE) -- OKX, a leading Web3 technology company, has issued updates for May 14, 2024. OKX Wallet Announces Integration of KyberSwap for Enhanced Decentralized...
Aspo's financial targets and dividend policy updated, and profitability metric of the guidance changed
May 14, 2024 01:05 ET
|
Aspo Oyj
Aspo PlcStock Exchange ReleaseOther information disclosed according to the rules of the ExchangeMay 14, 2024, at 8:05 a.m.Aspo's financial targets and dividend policy updated, and profitability metric...